Oncology Institute of Southern Switzerland (IOSI)
Bellinzona, Switzerland
Person responsible for CTC programme: PD Dr. Sara De Dosso
Hospital overview
The Oncology Institute of Southern Switzerland (IOSI) is a non-surgical cancer centre covering the needs of the population in the Southern, Italian speaking, part of Switzerland. It comprises 5 clinics: medical oncology, radiation-oncology, haematology, palliative care, and clinical research. Overall, 60 physicians compose the 5 teams. The main centre is in the San Giovanni Hospital in Bellinzona, where the inpatient department, the direction and the research centre is located, but IOSI covers also the oncology needs of 3 other hospitals, in Lugano, Mendrisio and Locarno. The Institute follows at the moment approximately 8000 patients, with about 2000 new cases per year.
The Oncology Institute of Southern Switzerland is one of the largest clinical research centres in Switzerland. The three main areas of clinical research comprise new drugs development, lymphoproliferative diseases (lymphoma and chronic lymphocytic leukaemia) and prostate cancer. Other areas of development in clinical research include breast, lung and gastrointestinal cancer. The Institute has a central role in the Faculty of Biomedical Sciences of the Università della Svizzera Italiana (USI)
A training period in our Institute is particularly suitable for colleagues interested in experiencing a very collaborative, multidisciplinary and organised functioning, adapted to the reality of medium sized hospitals.
CTC programmes offered
1. Hematological malignancies |
|
| Discipline: | Hematology |
| Programme mentors: |
G. Stüssi, D. Rossi, E. Zucca, A. Stathis |
| Duration: | 3 - 6 months |
| Type: | Visiting Residency and Visiting Observership |
| Language requirements: | Before accepting, please note that candidates will be interviewed in Italian. Therefore, a minimum intermediate level of Italian is required. |
| Programme description: | 1-3 months in the hemato-oncology inpatient department (lymphomas, myelomas, leukemias, autologous transplantation), 2-3 months rotating through the autologous transplantation program, lymphoma clinic, leukemia clinic, myeloma clinic, hematology diagnostic laboratory, lymphoma research team. |
2. Solid tumors oncology |
|
| Discipline: | Medical Oncology, Palliative Care |
| Programme mentor: | S. De Dosso |
| Duration: | 3 - 6 months |
| Type: | Visiting Residency and Visiting Observership |
| Language requirements: | Before accepting, please note that candidates will be interviewed in Italian. Therefore, a minimum intermediate level of Italian is required. |
| Programme description: | 1-2 months in the oncology and palliative care inpatient department (all types of solid tumours), 2-3 months rotating through the GI, lung, breast, gynaecological, H&N and general oncology outpatient clinics. In addition, attendees will be able to see the organisation and functioning of our High Risk Clinic - Oncogetics, that deliver genetic counseling and evaluation for cancer predisposition testing. |
3. New drug development |
|
| Discipline: | Medical Oncology |
| Programme mentor: | A. Stathis, I. Colombo |
| Duration: | 3 - 6 months |
| Type: | Visiting Residency and Visiting Observership |
| Language requirements: | Before accepting, please note that candidates will be interviewed in Italian. Therefore, a minimum intermediate level of Italian is required. |
| Programme description: | Activity with both physicians in charge of study patients and with research nurses / data managers, to experience the clinical and administrative patient management, the preparation and the application of clinical protocols, team work, SOP and good clinical practice (GCP). |
4. Radiation oncology |
|
| Discipline: | Radiotherapy |
| Programme mentor: | T. Zilli, G. Pesce |
| Duration: | 3 - 6 months |
| Type: | Visiting Residency and Visiting Observership |
| Language requirements: | Before accepting, please note that candidates will be interviewed in Italian. Therefore, a minimum intermediate level of Italian is required. |
| Programme description: |
A customized program will be developed on the clinical, technical and dosimetric aspects of RT in the treatment of solid cancers i.e. SNC, head and neck, gastrointestinal, lung, breast, genitourinary, cutaneous and hematological ones i.e.lymphoma. The palliative role of RT will be analyzed too. |